These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 2410119

  • 1. Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.
    Winton EF, Hearn EB, Martelo O, Presant CA, Adler S, Vogler WR, Raney M, Logan T, Silberman HM, Omura GA.
    Cancer Treat Rep; 1985; 69(7-8):807-11. PubMed ID: 2410119
    [Abstract] [Full Text] [Related]

  • 2. Amsacrine in refractory adult acute leukemia: a pilot study of the Southeastern Cancer Study Group.
    Winton EF, Hearn EB, Vogler WR, Johnson L, Logan T, Raney M.
    Cancer Treat Rep; 1983 Nov; 67(11):977-80. PubMed ID: 6580070
    [Abstract] [Full Text] [Related]

  • 3. Amsacrine in refractory acute leukemia.
    Griffin JD, Maguire ME, Mayer RJ.
    Cancer Treat Rep; 1985 Nov; 69(7-8):787-9. PubMed ID: 3860296
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of acute myeloid leukemia with amsacrine and high-dose cytosine arabinoside: a phase II trial].
    Marit G, David B, Reiffers J, Broustet A.
    Bull Cancer; 1985 Nov; 72(1):37-41. PubMed ID: 3857082
    [Abstract] [Full Text] [Related]

  • 5. Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.
    Sung WJ, Kim DH, Sohn SK, Kim JG, Baek JH, Jeon SB, Moon JH, Ahn BM, Lee KB.
    Jpn J Clin Oncol; 2005 Oct; 35(10):612-6. PubMed ID: 16172175
    [Abstract] [Full Text] [Related]

  • 6. AMSA--a promising new agent in refractory acute leukemia.
    Lawrence HJ, Ries CA, Reynolds RD, Lewis JP, Koretz MM, Torti FM.
    Cancer Treat Rep; 1982 Jul; 66(7):1475-8. PubMed ID: 7046928
    [Abstract] [Full Text] [Related]

  • 7. Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study.
    Vogler WR, Preisler HD, Winton EF, Gottlieb AJ, Goldberg J, Brennan J, Grunwald H, Rai K, Browman G, Miller KB.
    Cancer Treat Rep; 1986 Apr; 70(4):455-9. PubMed ID: 3516395
    [Abstract] [Full Text] [Related]

  • 8. m-AMSA: phase II trial in advanced lymphoma and leukemia.
    Case DC.
    Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746
    [Abstract] [Full Text] [Related]

  • 9. Phase I and II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide in patients with acute leukemia.
    Arlin ZA, Sklaroff RB, Gee TS, Kempin SJ, Howard J, Clarkson BD, Young CW.
    Cancer Res; 1980 Sep; 40(9):3304-6. PubMed ID: 6933002
    [Abstract] [Full Text] [Related]

  • 10. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K, Ogawa M, Kimura I, Ohnoshi T, Yamada K, Masaoka T, Wakui A, Meguro S, Nagai K, Kitani T.
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3021-7. PubMed ID: 3464230
    [Abstract] [Full Text] [Related]

  • 11. A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893).
    Willemze R, Suciu S, Archimbaud E, Muus P, Stryckmans P, Louwagie EA, Berneman Z, Tjean M, Wijermans P, Dohner H, Jehn U, Labar B, Jaksic B, Dardenne M, Zittoun R.
    Leukemia; 1997 Mar; 11 Suppl 1():S24-7. PubMed ID: 9130688
    [Abstract] [Full Text] [Related]

  • 12. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
    Martino R, Guardia R, Altés A, Sureda A, Brunet S, Sierra J.
    Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
    [Abstract] [Full Text] [Related]

  • 13. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
    Sackmann-Muriel F, Fernández-Barbieri MA, Santarelli MT, Matus-Ridley M, Rosso A, Negri-Aranguren P, Cerutti I, Gomel M, Kvicala R.
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
    [Abstract] [Full Text] [Related]

  • 14. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 15. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
    Beran M, Jeha S, O'Brien S, Estey E, Vitek L, Zurlo MG, Rios MB, Keating M, Kantarjian H.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2377-84. PubMed ID: 9815637
    [Abstract] [Full Text] [Related]

  • 16. Phase II trial of vindesine in patients with acute leukemia.
    Sklaroff RB, Arlin Z, Young CW.
    Cancer Treat Rep; 1979 Dec; 63(11-12):2063-5. PubMed ID: 294307
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of amsacrine gluconate in refractory leukemia.
    Omura GA, Winton EF, Vogler WR, Zuckerman KS, Grillo-Lopez AJ.
    Cancer Treat Rep; 1983 Dec; 67(12):1131-2. PubMed ID: 6580948
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP, Miller DR, Tan CT.
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract] [Full Text] [Related]

  • 19. Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial.
    Thomas X, Elhamri M, Chelghoum Y, Reman O, Arnaud P, Raffoux E, Le QH, Tavernier E, Dombret H, Michallet M.
    Ann Hematol; 2005 Jun; 84(6):376-82. PubMed ID: 15782343
    [Abstract] [Full Text] [Related]

  • 20. Treatment of acute leukemia with amsacrine and high-dose cytarabine.
    Arlin ZA, Gaddipati J, Ahmed T, Mittelman A, Friedland M, Rieber E.
    Cancer Treat Rep; 1985 Sep; 69(9):1001-2. PubMed ID: 3839713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.